Substantial preclinical/clinical research, administrative, and mentoring experiences for 40 years in the University of Houston, College of Pharmacy (UHCOP). Research have been focused on translational drug development for anti-cancer therapy, and the endeavors have resulted in an FDA product, Busulfex®, and multiple patents of developed formulations, currently in preclinical and clinical development for treatments of lung, pancreatic, and prostate cancers. Expert in pharmaceutical formulation development, pre-IND development, IND-enabling preclinical and clinical PK/PD to enhance or optimize clinical therapies towards new treatments for cancer and infection. Recently, research work has been expanded to URM populations, pediatrics and neurologically injured/disordered patients.